Is Citigroup A Good Investment Right Now?

Citigroup Inc. (NYSE:C) recently made double the news, releasing the results for the third quarter of the year followed shortly by the announcement that CEO Vikram Pandit would be stepping down and would be replaced by Michael Corbat. Corbat had previously been head of the bank’s operations in the Europe, Middle East, and Africa (EMEA) region and has worked in many of Citi’s divisions including commercial banking and wealth management.

The numbers for the third quarter beat analyst expectations, which Citigroup Inc. had also done in each of the first two quarters of the year, despite being a decline from the third quarter of 2011. Specifically, net interest revenue was flat and non-interest revenue was down 23%, pulling total revenue down by 9% as net interest is the larger source of business. Total revenues were down 2% on a q/q basis. Net income was also down, by twice as much as revenue in both cases. Loans and deposits, meanwhile, were up; in some cases, there was a double-digit percentage increase from a year earlier.

APPALOOSA MANAGEMENT LP

Citi still trades at a substantial discount to book value at a P/B ratio of 0.6. We certainly wouldn’t say that it should be trading at book value- the situation in Europe, to which Citi has quite a bit of exposure, leads us to be skeptical of the book value of the bank’s assets- but this is still a low number. The beta is 1.9, reflecting the fact that bad macro conditions threaten an already questionable balance sheet. Citi has rallied this year, up 32%; this is a little over twice the return of the S&P 500. It currently trades at 8 times forward earnings estimates.

Citigroup Inc. was the most popular financial stock among hedge funds during the second quarter of the year, and was actually one of the ten most popular stocks as well. It was one of Appaloosa Management’s favorite stocks, as billionaire David Tepper’s fund increased its stake by 52% to a total of 9.3 million shares. This position had a market value of over $250 million at the end of June (find more of billionaire David Tepper’s favorite stocks). Fellow billionaire David Shaw’s D.E. Shaw more than doubled its own holdings of Citi, and had 1.8 million shares in its portfolio at the end of June (see more stock picks from D.E. Shaw).

We would compare Citigroup to Bank of America Corp (NYSE:BAC), JPMorgan Chase & Co. (NYSE:JPM), HSBC Holdings plc (NYSE:HBC), and Wells Fargo & Company (NYSE:WFC). Bank of America is the most similar to Citi in terms of its book valuation: it actually trades at a P/B of 0.5. Like Citi, its revenue and earnings were down in the third quarter versus a year earlier, and its beta is also 1.9. Bank of America trades at a premium to Citi on a forward earnings basis, with a P/E of 10 based on analyst consensus for 2013. This actually gives it the highest forward P/E of this peer group. Even Wells Fargo- which trades at a premium to the book value of its equity, at a P/B of 1.2- carries a forward P/E of 9. We also like that Wells Fargo has been experiencing growth in its business, and the gap between its and Citi’s valuation multiples has been closing enough that we think the two banks are starting to look similarly attractive.

JPMorgan Chase and HSBC both trade at 8 times consensus earnings for 2013. HSBC does offer a higher dividend yield- at 3.7% to JPMorgan Chase’s 2.9%- but JPMorgan Chase did well in the third quarter in terms of growth (earnings were up 34% from the same period in 2011), trades at a discount to book value at a P/B of 0.8 (HSBC trades at book value), and actually trades at only 9 times trailing earnings, meaning it has to see little growth to meet analyst targets.

We don’t like Bank of America as a long idea anymore (though the stock has done well over the last few months). HSBC also seems questionable from a value perspective. We would say that Citi, JPMorgan Chase, and Wells Fargo form a consistent continuum where the more stable JPMorgan Chase and the considerably more reliable Wells Fargo trade at appropriately higher multiples with little opportunity for pair trades between them.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!